Ofloxacin
Paul A. Pham, Pharm.D.
,
John G. Bartlett, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Acute exacerbation of chronic bronchitis
(AECB)
Community-acquired pneumonia
(CAP)
Pelvic Inflammatory Disease
(PID)
Endocervical and urethral
gonorrhea
(note: high resistance rates in U.S. and worldwide, no longer recommended) and chlamydia infections.
Nongonococcal
urethritis
and
cervicitis
due to
C. trachomatis
.
Uncomplicated and
complicated UTI
Prostatitis due to
E. coli
Skin and soft tissue infections
Otitis externa
, chronic suppurative otitis media,
otitis media
(otic solution)
Conjunctivitis
,
keratitis
and corneal ulcers (ophthalmic solution)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Peritonitis, spontaneous bacterial & secondary
Proctitis
[sexually transmitted]
Sexually-associated reactive arthritis (SARA)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved